Liver function may affect how Weight-Loss drug petrelintide works
NCT ID NCT07682818
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study tests how the experimental weight-loss drug petrelintide is processed in people with mild to moderate liver impairment compared to those with healthy livers. Researchers will measure drug levels in the blood after a single injection. The goal is to see if liver problems change how the drug behaves, which could guide future dosing recommendations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Petrelintide (ZP8396)
- What this could lead to
- If petrelintide behaves similarly in people with liver issues, it may be safe to use in a broader population for weight management.
- What could go wrong
- This is an early-phase, small study (36 people) focused on drug processing, not on weight loss or safety. Results may not predict real-world outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centrum Badan Klinicznych Piotr Napora Lekarze sp.p.
RECRUITINGWroclaw, Poland, 51-162, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Summit Clinical Research s.r.o.
RECRUITINGBratislava, Bratislava Region, 831 01, Slovakia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Summit Clinical Research s.r.o.
RECRUITINGMalacky, Malacky, 901 01, Slovakia
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver function may change how belapectin works in the body
- Liver function may change how ammoxetine works
- Liver health may change how a promising cancer drug works in the body
- Liver health may change how body handles inhaled lung drug
- Liver function and drug processing: a safety study
- New cholesterol drug tested in liver patients